Alm. Brand A/S
4.3.2025 17:28:45 CET | Globenewswire | Press release
Alm. Brand A/S - Completion of proportionate buyback of shares from Foreningen Alm. Brand af 1792 fmba
Alm. Brand A/S - Completion of proportionate buyback of shares from Foreningen Alm. Brand af 1792 fmba
Today, Alm. Brand Group A/S has completed a block buyback of 47,710,542 shares for a total amount of DKK 764,8 million from Foreningen Alm. Brand af 1792 fmba, equivalent to 47.8% of the total share buyback of DKK 1.6 billion announced on 22 January 2025 through company announcement no. 4/2025. The buyback is related to the divestement of Energy & Marine. The block buyback was completed to maintain Foreningen Alm. Brand af 1792 fmba’s percentage ownership interest in Alm. Brand Group A/S following completion of the total share buyback. The block buyback was completed at the closing price of the company’s shares on Nasdaq Copenhagen on 4 March 2025.
In accordance with section 31 of the Danish Capital Markets Act, Alm. Brand A/S hereby announces that the portfolio of treasury shares now exceeds 5% of the shares in Alm. Brand A/S.
Contact
Please direct any questions regarding this announcement to:
Head of IR, Rating and ESG reporting
Mads Thinggaard
Mobile no. +45 2025 5469
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma5.10.2026 18:30:00 CEST | Press release
Zealand Pharma – Completion of share buy-back program and related transactions (week 40 and 41, 2026)
Optica5.10.2026 18:13:09 CEST | Press release
Three Researchers Awarded 2026 Nobel Prize in Physiology or Medicine for Their Pioneering Contributions to Optogenetics
Poppulo5.10.2026 17:59:36 CEST | Press release
Poppulo Named a Challenger in the 2026 Gartner® Magic Quadrant™ for Intranet Packaged Solutions
Idorsia Pharmaceuticals Ltd5.10.2026 17:45:00 CEST | Press release
Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension
Sironax USA, Inc.5.10.2026 17:00:00 CEST | Press release
Sironax Named to Fierce Biotech’s “Fierce 15” List of the Most Innovative and Promising Private Biotechs of 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom